Recent Headlines
Four Finalists Selected for BioWest 2010 Venture Showcase Competition, Presenting Life-Changing Technologies
Cutting-edge development of a universal influenza vaccine, creation of an innovative hybridCpeptide manufacturing process, groundbreaking wastewater treatment through a new algae production system, and a revolutionary nontoxic surface treatment to control the growth of bacteria in hospitals, comprise the four finalists in this year’s BioWest Venture Showcase competition. - September 13, 2010 - Colorado BioScience Association
Colorado's Emmy® Award Winning Heroine Dr. Temple Grandin Keynotes CBSA Awards Dinner at 2010 BioWest Conference & Expo
General registration is now open for the Rocky Mountain Region’s Premier Bioscience Conference & Expo, BioWest 2010. More than 700 participants are expected at this year’s event, September 29-30, at the Grand Hyatt (1750 Welton) in Denver. Headlining the Annual Awards Dinner during the 2010 BioWest Conference is Dr. Temple Grandin, noted author, speaker, scientist and autism expert who leads an impressive line up of national and international industry speakers and panelists. - September 07, 2010 - Colorado BioScience Association
New Hope Fertility Centre Launches Frozen Egg Banking: The Next Logical Step in IVF
In Vitro Fertilization is a technology on the cutting edge of medical science. It was a science that was created to meet a basic human need, to bring the gift of childbirth to parents who were biologically unable to conceive on their own. - September 04, 2010 - New Hope Fertility Center
National Institutes of Health Award a $1.7M SBIR Grant to MicroTransponder to Develop a Neurostimulation-Based Therapy to Treat Tinnitus
MicroTransponder, Inc., a privately-held medical device company, announced that it has been awarded a $1.7M SBIR grant from the National Institute on Deafness and Other Communication Disorders (NIDCD) to develop a neurostimulation-based therapy for the treatment of Tinnitus. This project builds... - September 01, 2010 - MicroTransponder Inc.
C.R. England and Insight Diagnostics, Inc. Announce Successful Collaboration Enhances Employee Productivity
C.R. England and Insight Diagnostics, Inc. (IDI) have formed a strategic alliance to provide state of the art technology to enhance patient care at England’s Lakeside Clinic. IDI’s FDA approved Electrodiagnostic Functional Assessment (EFA) is a Class II diagnostic device and service protocol for assessing soft tissue injuries. - August 27, 2010 - Insight Diagnostics Inc
New England Fertility Institute of Stamford Connecticut to Attend London Fertility Show November 5th and 6th
The New England Fertility Institute and Dr. Gad Lavy Medical Director will be attending and exhibiting at the London Fertility Show in the Olympia Convention Center November 5th and 6th 2010. Dr. Lavy will be doing complimentary consultations for individuals and couples interested in egg donation and gestational surrogacy in the United States. - August 27, 2010 - New England Fertility Institute
CW Optics Announces Clinical Trial of Breakthrough Technology for Wound Imaging for Diabetics
CW Optics, Inc. announced today a clinical trial at Richmond's Chippenham and Johnston-Willis (CJW) Medical Center to investigate the safety and efficacy of WoundImager®, an advanced optical imaging device for monitoring the effectiveness of therapeutic management of chronic wounds caused by... - August 27, 2010 - CW Optics, Inc.
CW Optics Announces Clinical Trial of Breakthrough Technology for the Detection of Intravenous Infiltration
CW Optics, Inc. announced today the launch of a clinical trial at the Virginia Commonwealth University Health System to investigate the safety and efficacy of ivWatch®, a novel optical device for monitoring intravenous (IV) infusion sites for infiltration. Each year, there are approximately 150... - August 27, 2010 - CW Optics, Inc.
Bio-Med QC Offers an Indiana Pharmacy Exclusive
Bio-Med QC has recently designed the most comprehensive and the most effective CSP quality assurance microbiology system available. The Bio-Shield AT system includes added value, on site training and saves you money over the alternative options that provide no microbiology support. Bio-Med QC has... - August 26, 2010 - Bio-Med QC
New Hope Fertility Center Offers Unique Blastocyst Guarantee
New Hope Fertility Center, a leader in Egg Donation, now offers a unique guarantee designed to dramatically increase successful implantation rates and embryo viability. - August 20, 2010 - New Hope Fertility Center
DDC Launches UK Mobile DNA Sample Collection Service
DNA Diagnostics Centre has launched a new service enabling private clients, immigration law specialists, family and child law solicitors to have DNA samples collected by a mobile DNA collection team throughout the United Kingdom. - August 18, 2010 - DNA Diagnostics Centre
CEO Will Rosellini and MicroTransponder Inc. Named Finalists for the 10th Annual Tech Titans Awards
The MTBC has named CEO Will Rosellini a finalist for the Tech Innovator category and MicroTransponder a finalist for the Emerging Company Horizon category for the 10th Annual Tech Titan Awards in Texas. - August 17, 2010 - MicroTransponder Inc.
Clinical Trials in Russia. 2nd Quarter 2010.
The Federal Service on Surveillance in Healthcare and Social Development of the Russian Federation (alias RosZdravNadzor, RZN) approved 178 new clinical trials of all types including local and bioequivalence studies during the second quarter of 2010 demonstrating a 38% increase over the corresponding period of last year. - August 14, 2010 - Synergy Research Group
ARUP Laboratories Presents Recent Research at Two Major Association Meetings
ARUP Laboratories staff has presented some recent research findings at two major meetings during the first two weeks of August. Posters were presented at the AMLI and ACM conferences. - August 12, 2010 - ARUP Laboratories
Colorado BioScience Association Seeks Region’s Top Innovators for Venture Showcase Competition at 2010 BioWest Conference & Expo
The organizers of the annual BioWest Conference & Expo are again looking for the best bioscience start-ups in the region as candidates for this year's $7,500 Dorsey & Whitney Venture Showcase Award. Four companies will be chosen to present at the showcase on Wednesday, September 29, 2010, and will be judged by a panel of venture capitalists. Deadline for entry is Friday, August 20. - August 04, 2010 - Colorado BioScience Association
Novus Biologicals Releases Two New Posters to Guide Antibody Research
Novus revealed two new posters at the ISSCR 8th Annual Meeting between June 16 - 19 – a fluorescent labels poster and a stem cell signalling pathway poster. The fluorescent labels poster displays all fluorophores that Novus offers conjugated to their primary antibodies. The stem cell... - August 04, 2010 - Novus Biologicals Europe
Clinical Pharmacology Study Group (CPSG) Announces Open Enrollment for Psoriatic Arthritis
The Clinical Pharmacology Study Group (CPSG) is currently participating in several clinical trials for psoriatic arthritis in its Worcester, MA facility. Subjects who enroll in a clinical trial are carefully selected from a list of inclusion and exclusion criteria designed to ensure safety for the... - July 31, 2010 - Clinical Pharmacology Study Group
Clinical Pharmacology Study Group (CPSG) Announces Open Enrollment for Diabetic Neuropathy
The Clinical Pharmacology Study Group (CPSG) is currently participating in several clinical trials for diabetic peripheral neuropathy in its Worcester, MA facility. Diabetic neuropathy is a common complication of diabetes in which nerves are damaged as a result of high blood sugar levels. Symptoms... - July 31, 2010 - Clinical Pharmacology Study Group
American Society for Biochemistry and Molecular Biology Honors 11 Outstanding Scientists
The American Society for Biochemistry and Molecular Biology last week named 10 scientists the winners of the nonprofit’s annual awards. Another winner was announced earlier this year. The recipients, who will give talks at the society’s annual meeting April 9-13 in Washington, D.C., are... - July 30, 2010 - American Society for Biochemistry and Molecular Biology
International Stem Cell Corporation Planning European Subsidiary
International Stem Cell Corporation (OTCBB:ISCO) announced that it had entered into a Memorandum of Understanding with ARG Vermogensverwaltung AG ('ARG'), a German Investment Fund, to create a new European subsidiary ('ISCO Europe') to be funded with up to $10 million of capital derived from ARG... - July 28, 2010 - International Stem Cell Corporation
Glissandra™ Skincare Announces the Boutique Retail Launch of Its Innovative Anti-Aging Skincare Products at Toronto’s PIR Cosmetics
Glissandra™ Skincare is pleased to announce the boutique retail launch of its innovative anti-aging skincare products at PIR Cosmetics, widely recognized in the beauty industry as Canada's leading retailer of hard-to-find, niche cosmetics brands. Glissandra products target the leading cause of aging: mitochondrial decay. - July 28, 2010 - Glissandra Skincare
Pardee Grant Will Further Pancreatic Cancer Research
Seventy-five percent of pancreatic cancer patients die within the first 12 months of their diagnosis. In a collaborative project, George Prendergast, Ph.D., Professor, President & CEO at the Lankenau Institute for Medical Research (LIMR) and Iraimoudi Ayene, Ph.D., Associate Professor at LIMR, received a one-year $125,000 grant from the Elsa U. Pardee Foundation to conduct the research project entitled Novel Immunochemotherapy for Pancreatic Cancer Treatment. - July 28, 2010 - Lankenau Institute for Medical Research
ALPCO Diagnostics Launches First Commercially Available Sclerostin ELISA in the U.S.
ALPCO Diagnostics recently launched an ELISA specific for measuring human sclerostin in serum and plasma. Sclerostin inhibits osteoblast activity via antagonism of the wnt signaling pathway and plays a key role in the regulation of bone formation. Reports show that sclerostin expression and/or... - July 27, 2010 - ALPCO
Health Decisions Appoints New CTO to Streamline Its HD360° Trial Management Platform
CRO hires Bryan Minihan to boost data integration and flow, providing sponsors and sites with a one-stop web portal for near real-time study information. - July 24, 2010 - Health Decisions
ALN Publishes Article on Whole Animal Database by Noesys Data
Article on Artios Software Suite is published by ALN, a respected industry publication covering animal research institutions and markets. - July 21, 2010 - Noesys Data
$1.85 Million Grant Explores New Treatment for Rheumatoid Arthritis
Affecting more than 1.3 million people in the United States alone, rheumatoid arthritis (RA) is a debilitating disease that causes pain, swelling, and stiffness in the joints. Dr. Laura Mandik-Nayak, Assistant Professor at the Lankenau Institute for Medical Research (LIMR), received a five-year,... - July 21, 2010 - Lankenau Institute for Medical Research
Glycemion Strategies Announces the Availability of a New HbA1c & HS-CRP Combination Test for Dental Professionals
Glycemion Strategies announces the availability of a combination test specifically developed by Healthy Life Labs for diabetes and inflammation to serve the 150,000 dental professionals in the US and the millions of at-risk patients they serve. - July 18, 2010 - Healthy Life Laboratories
Healthy Life Laboratories Appoints Henry Warner as Computer Sciences Director
Healthy Life Laboratories, Inc., a clinical research laboratory in north suburban Chicago has appointed Henry A. Warner, MS as its Director of Computer Sciences. - July 17, 2010 - Healthy Life Laboratories
Re-Uniting Families on the Increase with DNA Diagnostics Centre UK
With the first UK ‘walk-in’ DNA Testing facility now open, DNA Diagnostic Centre UK confirms large numbers of families are being re-united through DNA immigration testing services. - July 14, 2010 - DNA Diagnostics Centre
International Stem Cell Corp. and India's Largest Eye Hospital to Develop Stem Cell-Based Treatment for Corneal Vision Impairment
International Stem Cell Corporation and Sankara Nethralaya Eye Hospital, a nonprofit medical facility, are collaborating to develop ISCO's 'CytoCor™' stem cell-derived corneal tissue. The goal is to use CytoCor, human tissue derived from pluripotent human stem cells, to treat corneal blindness and vision impairment. - July 11, 2010 - International Stem Cell Corporation
Unimed-Midwest Introduces Wrap-It™ Bandages – Versatile Wraps for Uniform Compression and Support
Wrap-It™ Bandages with hook and loop closures are ideal compression wraps and supports for medical needs and sports injuries. Available in a variety of sizes, these breathable, reusable bandages are machine washable, sterilizable and latex-free. - July 09, 2010 - Unimed-Midwest, Inc.
Consumers Report Positive Results in Reducing Symptoms of Lactose Intolerance with Lactagen
Customer Experience Reports indicate relief from the symptoms of lactose intolerance using the Lactagen® program of colonic adaptation. - July 02, 2010 - Lactagen
Stemedica Announces the Appointment of Dr. Cesar Amescua Garcia as Medical and Regulatory Affairs Director – Latin America
Dr. Amescua will be responsible for liaison with regulatory agencies in Latin America regarding approvals of Stemedica’s allogeneic adult stem cell products for use in clinical (human) trials which follow the criteria required by the FDA in the United States. - July 02, 2010 - Stemedica Cell Techechnologies
Colorado BioScience Association Commends Boettcher Foundation on Historic Launch of Webb-Waring Biomedical Research Program & Inaugural Class of 'Boettcher Investigators'
Colorado BioScience Association commends Boettcher Foundation on launching the new Webb-Waring Biomedical Research Program and its 2010 (Inaugural) Class of Boettcher Investigators. This new grant program will ensure that the Webb-Waring legacy lives on both through the discovery of new knowledge that improves human health and through the investment in and advancement of early-career scientists. - July 01, 2010 - Colorado BioScience Association
Clinical Pharmacology Study Group (CPSG) Announces Open Enrollment for Rheumatoid Arthritis Studies
The Clinical Pharmacology Study Group (CPSG) is currently participating in several clinical trials for rheumatoid arthritis in their Worcester, MA facility. Subjects who enroll in a clinical trial are carefully selected from a list of inclusion and exclusion criteria designed to ensure safety for... - June 25, 2010 - Clinical Pharmacology Study Group
Economic Development Executive Holli Baumunk Named President & CEO of the Colorado BioScience Association Effective July 12
Holli Baumunk, Vice President of the Metro Denver Economic Development Corporation for the past seven years, has been named President & CEO of the Colorado BioScience Association (CBSA) July 12. The announcement is made by Rick Jory, CBSA Board Chairperson, who says Baumunk was unanimously... - June 24, 2010 - Colorado BioScience Association
Houston IVF Announces Fertility Breakthrough with First Live Births in Texas from Frozen Egg
Houston IVF recently announced the first live births of children conceived using oocyte cryopreservation, also known as egg freezing, in the state of Texas. The births pave the way to successful pregnancies for women who face cancer treatment or women who want to delay childbearing due to their career or lifestyle situations. - June 24, 2010 - Houston IVF
"Love Simple," S.L.E. Lupus Foundation Donation Drive Drawing to a Close
June 21 Last Day for 30% of Sales on iTunes to Help Raise Funds, Awareness for Lupus - June 19, 2010 - S.L.E. Lupus Foundation
Clinical Pharmacology Study Group (CPSG) Announces Open Enrollment for Fibromyalgia Studies
The Clinical Pharmacology Study Group (CPSG) is currently participating in several clinical trials for fibromyalgia in their Worcester, MA facility. Subjects who enroll in a clinical trial are carefully selected from a list of inclusion and exclusion criteria designed to ensure safety for the... - June 18, 2010 - Clinical Pharmacology Study Group
ALPCO Diagnostics Exclusively Offers Animal NGAL Assays from BioPorto
BioPorto Diagnostics has awarded ALPCO Diagnostics exclusive distributorship for its animal NGAL ELISAs to the North American market. BioPorto’s prominence is unrivaled in immunoassays for measuring NGAL (neutrophil gelatinase associated lipocalin) – the breakthrough kidney injury... - June 17, 2010 - ALPCO
Discover Past Secrets for Father’s Day with DNA Diagnostics Centre UK
DNA Diagnostics Centre UK (DDC) the leading DNA testing laboratory announces complimentary DNA sample collection in time for father’s day. - June 16, 2010 - DNA Diagnostics Centre
Romantic Comedy Film "Love Simple" Donating Proceeds to S.L.E. Lupus Foundation
June 14—June 21, 30% of Sales on iTunes Will Help Raise Funds, Awareness for Lupus - June 12, 2010 - S.L.E. Lupus Foundation
AsymmetRx Medical Signs Multi Year Agreement with Ventana Medical a Member of the Roche Group
AsymmetRx Medical, Inc. an Acton, MA based Biotechnology Company, announced the signing of a license agreement with Ventana Medical, A member of the Roche Group. This agreement provides Ventana with the exclusive license and distribution rights of their patented Prostate Cancer Diagnostic tool... - June 11, 2010 - AsymmetRx Medical, Inc.
International Stem Cell Corporation's Parthenogenetic Stem Cell Patent Approved by the United States Patent and Trademark Office
International Stem Cell Corporation announced that the United States Patent and Trademark Office has granted ISCO a patent relating to the company’s development of human non-embryonic parthenogenetic stem cells. Human parthenogenetic stem cells are a new type of pluripotent stem cell that allows immune matching to potentially solve critical immune rejection problems, that could create a universal cell benefiting most the of the world's population, and that avoids ethical issues. - June 10, 2010 - International Stem Cell Corporation
Health Decisions CEO Explores Adaptive Monitoring Techniques for Late-Stage Clinical Studies in June 14 DIA Session
Dr. Michael Rosenberg will describe how fast access to metrics, flexible processes, and automated technology enable study monitors to increase efficiency - June 10, 2010 - Health Decisions
ALPCO Diagnostics Prepares for Launch of Unique Immunoassays
ALPCO Diagnostics announces the recent hiring of Leon F. Hebert Jr., Ph.D. As ALPCO’s new Diabetes and Obesity Product Manager, Dr. Hebert will be charged with overseeing the launch of several new ELISA research tools, including: Mouse Proinsulin ELISA, Rat Proinsulin ELISA, Mouse C-peptide... - June 09, 2010 - ALPCO
Application of Flow Cell to Continuous Processing Technology Webinar
METTLER TOLEDO announced that the webinar – The Application of the ReactIR Flow Cell to Continuous Process Technology - is now available on-demand. Presented by Professor Steven Ley of the University of Cambridge, METTLER TOLEDO is proud to offer this free online seminar that discusses the application of the ReactIR Flow Cell inline using various meso and micro scale flow chemistry equipment. - June 05, 2010 - METTLER TOLEDO
The Allogeneic Adult Stem Cells Company Announcing Appointment of Dr. Lev Verkh
Lev Verkh is now a part of Stemedica, the allogeneic adult stem cells manufacturing company for effective stem cell clinical trials, thus improving the life of humans. - June 05, 2010 - Stemedica Cell Techechnologies
Buchberger Laboratories Austria Unveiling WOYZEK® Nicotine Inhaler
For the first time Buchberger Laboratories Austria is releasing detailed information on its most promising pharmaceutical product candidate – the WOYZEK® Nicotine Inhaler – a cigarette smoking cessation aid for medium and long-term use. - June 04, 2010 - Buchberger Laboratories Austria
Unimed-Midwest Introduces Insta-Cold Compress, Environmentally Friendly Instant Cold Pack
The Insta-Cold Compress instant cold pack is an easy to use, high-performing ice pack which is environmentally friendly and is composed of non-hazardous materials, unlike traditional instant ice packs. - June 03, 2010 - Unimed-Midwest, Inc.